Femme et Homme
- | Pays :
- Bosnia and Herzegovina
- Germany
- | Organes : -
- | Spécialités : -
Extrait
The purpose of the study is to evaluate the efficacy and the safety of AMT2003 in cancer patients with advanced disease. The primary evaluation criterion is clinical benefit response.
Critère d'inclusion
- gastrointestinal cancer ,Prostate cancer ,Genital Neoplasms, Female